FDA also approved four (36%) of the 11 drugs that the drug advisory
committees voted against, including products that were opposed by
almost all the committee members."
"Whatever the reasons, many
of today's FDA drug and device advisory committees are rubber stamps
for approval almost every time they meet. Moreover, even when an
overwhelming majority recommend "nonapproval," there is a good chance
that FDA officials will approve the product anyway. "